Agoracom Blog

Else Nutrition $BABY.ca $BABYF has Developed a Breakthrough, Patent-Pending Clean Processing of Ingredients for its Infant Formula $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 9:53 AM on Monday, February 22nd, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Else has developed a breakthrough, proprietary process to further ensure the safety of the formula.
  • This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.

VANCOUVER, BC , Feb. 22, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , announces as part of its progress towards commercializing a clean label, dairy-free and soy-free, plant-based infant formula, Else has developed a breakthrough, proprietary process to further ensure the safety of the formula. This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.

This new process builds on the company’s already clean and most natural production process that ensures the highest quality standards – it does not use harsh chemicals or detergents (commonly used in the industry) and does not impact the formula’s amino acids or other macronutrients.

“The World Health Organization considers the first 1000 days of life as critically important to long term health and wellness. It’s the window of time where optimum brain and immune system development is established. Infant formula is the exclusive form of nourishment for many babies during this critical period of development. The recent consumer and regulatory call to action is especially prudent to the formula category. Else Nutrition is voluntarily and proactively changing the way they source ingredients, manufacture their products, and think about food safety all in an effort to optimize environmental and public health now and into the future,” said Jaclyn Bowen MPH, MS food and consumer products safety and systems engineer and Executive Director of Clean Label Project.

“We’re leading a clean revolution, disrupting the baby food industry by setting a new standard in quality, transparency and sustainability. This latest development brings us even closer to bringing clean label, plant-based, minimally processed infant formula to wanting parents worldwide,” said Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition.

The novel pre-process was under development for nearly a year. A full Pilot stage was successfully completed and tested recently at the company’s innovation center in Northern Israel , positively demonstrating reduction of specific elements levels.

Already a recipient of The Clean Label Project’s Purity Award (an honor only bestowed after products are tested for over 400 contaminants and heavy metals and meet the organization’s highest standard) for its Plant-Based Complete Nutrition for Toddlers product, Else continues its commitment to ‘cleaning up’ the baby/toddler nutrition aisles with safe, clean label products of the highest quality.

Else is proud to share this exciting development and its continued commitment to baby food safety and quality, in light of a recent congressional report that revealed that many baby food products offered by leading manufacturers contain significant levels of toxic heavy metals.

Else’s ‘Beyond Organic’ Processing

Else Nutrition is primarily made of almonds, tapioca and buckwheat; three core ingredients that go through a clean, all-natural process that provides the protein, carbohydrates, and fat directly from the whole plants, along with phytonutrients, fiber, vitamins and minerals nature intended to provide optimal nourishment for children. Else is free of dairy, soy and corn-syrup, and is made with non-GMO ingredients. It is made using a clean, most natural and sustainable industry process.

Read More: https://agoracom.com/ir/ElseNutritionHoldings/forums/discussion/topics/755787-else-nutrition-has-developed-a-breakthrough-patent-pending-clean-processing-of-ingredients-for-its-infant-formula/messages/2304698#message

ThreeD Capital Inc. $IDK $IDKFF Announces DTC Eligibility of its Common Shares Trading in the United States $INTL.ca $IP.ca $IPNFF $PKK.ca $PKKFF $MTRX $RACMF

Posted by AGORACOM-JC at 9:45 AM on Monday, February 22nd, 2021
IDK-square-for-blog
  • Now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States.
  • The Company’s common shares are traded on the OTCQB under the symbol “IDKFF”.

TORONTO, Feb. 22, 2021 — ThreeD Capital Inc. (the “Company” or “ThreeD”) (CSE:IDK) (OTCQB:IDKFF) is pleased to announce that the Company’s common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States. The Company’s common shares are traded on the OTCQB under the symbol “IDKFF”.

DTC is a subsidiary of the Depository Trust and Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly traded companies. DTC services reduces costs and accelerates the settlement process for investors and brokers trading Canadian securities in the United States.

Sheldon Inwentash, CEO of ThreeD commented, “We are thrilled with obtaining DTC eligibility, as it represents an important step forward in increasing liquidity, broadening our shareholder base and building a strong presence for the Company within the US capital markets sphere.”

About ThreeD Capital Inc.

ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.

For further information:

Jakson Inwentash
Vice President Investments
[email protected]
Phone: 416-941-8900 ext 107

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Read More: https://agoracom.com/ir/threedcapital/forums/discussion/topics/755784-threed-capital-inc-announces-dtc-eligibility-of-its-common-shares-trading-in-the-united-states/messages/2304695#message

Mountain Valley MD $MVMD $MVDMF to Include Testing of South African Mutation in Upcoming COVID-19 BSL-4 Clearance Work $CTLT $MRNA $NVAX

Posted by AGORACOM at 9:29 AM on Monday, February 22nd, 2021
  • Testing South African COVID-19 variant with the Company’s new solubilized Ivermectin technology.
  • Mutation is now the most dominant form of the COVID-19 virus in South Africa

Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce that it will be testing the new B.1.351 South African COVID-19 variant in its upcoming Bio Safety Level 4 (“BSL-4”) lab study, which is analyzing viral clearance efficacy with the Company’s new solubilized Ivermectin technology.

According to the World Health Organization*, the mutated B.1.351 COVID-19 variant is now the most dominant form of the COVID-19 virus in South Africa and is believed to be more infectious and thus easier to spread. As the COVID-19 virus continually mutates, researchers are assessing the impact of the current vaccines that are in distribution to understand if they may be rendered less effective or even noneffective**.

“We felt it was critical to look at this new South African COVID-19 variant given the immediate complexities we are seeing with the pace of vaccine rollout and the high probability that current vaccines will not be as effective, if at all, against these emerging mutations,” stated Dennis Hancock, President and CEO of Mountain Valley MD. “It is important to us across our broad human health objectives that our solubilized Ivermectin technology can be confidently applied as the broadest COVID-19 therapeutic and number one choice in the world when a vaccine falls short.”

The Company has previously communicated that it believes its solubilized Ivermectin would be suitable for a broad therapeutic across a wide range of viruses in the future, not just limited to COVID-19.

“It is not clear if the current vaccines will protect you from the new variants and early information is that vaccines are not as effective on the mutations. We are attempting in our work with the BSL-4 lab to target novel COVID-19 variants that would prove Ivermectin’s broad activity in interfering with the replication of the virus and thus broadly applies across multiple variants versus being specific to a variant the way a vaccine would be,” stated Mike Farber, Director of Life Sciences at MVMD.

As communicated in the Company’s news release on January 27, 2021, the BSL-4 trial will be the first of its kind ever conducted with human grade solubilized Ivermectin anywhere in the world and its design was led by the Company’s key scientific advisor, Dr. John Clements. Dr. Clements is Emeritus Professor of Microbiology and Immunology at Tulane University School of Medicine and has over 35 years of experience in vaccine, immunology and infectious diseases research and development, with a distinguished scientific career focused on developing and evaluating vaccines for a wide range of infectious diseases globally.

Read More: https://agoracom.com/ir/MountainValleyMD/forums/discussion/topics/755796-mountain-valley-md-to-include-testing-of-south-african-mutation-in-upcoming-covid-19-bsl-4-clearance-work/messages/2304707#message

St-Georges Eco-Mining $SX $SXOOF Reports on Initial Battery Recovery Test Results $NNX.ca $OM.ca $ICM.ca $ATAO

Posted by AGORACOM at 9:14 AM on Monday, February 22nd, 2021
  • Initial tests on lithium-ion batteries successful in the recovery of lithium, nickel and cobalt found as a coating on aluminium foil in the core of the batteries.
  • Leached more than 99% of the cobalt and of the nickel contained in the batteries.

St-Georges Eco-Mining Corp. (CSE:SX) (OTC:SXOOF) (FSE: 85G1) (CNSX:SX.CN) is pleased to disclose that its initial tests conducted on an array of lithium-ion batteries have been successful in confirming that the selective leach, conducted with its proprietary blend of acids, allows for the recovery of the lithium, nickel and cobalt that are found as a coating on aluminium foil in the core of the batteries.

The Company’s metallurgical team was able to leach more than 99% of the cobalt and of the nickel contained in the batteries. Furthermore, the aluminium foil used to hold the different metals in the batteries’ core remains intact and can be recycled.  

Company scientists are comfortable that the results obtained on these metals are repeatable and should scale. Initial lithium test results have been in line with expectations and require additional tests at scale prior to disclosure. These additional tests are ongoing, and results are expected sometime in March.

Fig. 1 The metals in solution, to the left the lithium / cobalt circuit, to the right the nickel copper circuit.

For testing, batteries were dismantled at the Company’s contracted pilot plant facility, CIMMS, under the supervision of qualified chemists and metallurgists. Enrico Di Cesare, St-Georges VP Research & Development, established the protocol and supervised the process. The batteries were dismantled manually, and the cores were immersed in St-Georges’ proprietary leach solution for 30 minutes. The Company expects to optimize and reduce this exposure duration with the aim of bringing it closer to the 5 min leach time required by the Nevada clays. Aluminium was taken out of the solution in its solid form and set aside. No test for residues was conducted on the aluminium in the preliminary tests. Metals were then targeted for recuperation in solution. The powders obtained were tested on-site and sent for independent testing by CIMMS

Read More: https://agoracom.com/ir/St-GeorgesEco-Mining/forums/discussion/topics/755797-st-georges-reports-on-initial-battery-recovery-test-results/messages/2304710#message

Candente Copper $DNT Corporate Update and Engineering Study Proposals Under Evaluation For Canariaco Copper Deposit $CDG.ca $FCX.ca $TECK.ca $FSUGY $PER.ca

Posted by AGORACOM at 9:01 AM on Monday, February 22nd, 2021
http://blog.agoracom.com/wp-content/uploads/2020/08/candente-copper-for-blog1.jpg
  • Engineering studies to identify and define various value add options for the development of the Cañariaco Project.
  • First goal is to define/identify a smaller, higher grade, start up option for Cañariaco with a smaller CapEx and accelerated payback period

Candente Copper Corp. (TSX:DNT, BVL:DNT) (“Candente Copper”, “Company”) is pleased to announce that it has received and is reviewing proposals from two internationally acclaimed engineering firms for engineering studies to identify and define various value add options for the development of the Cañariaco Project.

The first goal of the engineering study is to define/identify a smaller, higher grade, start up option for Cañariaco with a smaller initial capital expenditure (“CapEx”) and accelerated payback period. This is expected to be able to be permitted and financed to production more quickly than the larger option. The intention would be that once the development capital is paid back, the smaller operation could then be expanded to fully recognize the value of the large copper-gold resource that exists at Cañariaco.

The second goal is to explore other potential options with a mind to establish both cost efficiencies and environmental, social and governance (“ESG”) friendly development options. Current industry wide ESG initiatives and responsible investing is driving innovation in environmentally friendly, sustainable development and finance products. This innovation has been accelerated by the COVID-19 pandemic and increased urgency around the 17 UN Sustainable Development Goals, resulting in many new development options to consider now.

Read More: https://agoracom.com/ir/CandenteCopper/forums/discussion/topics/755788-corporate-update-and-engineering-study-proposals-under-evaluation/messages/2304699#message

American Creek $AMK “Breaking The Sound Barrier” John Newell and Mining Stock Watch $TUD.ca $ESK.ca $SEA.ca $STNG.ca

Posted by AGORACOM at 8:41 AM on Monday, February 22nd, 2021
  • “Can you see the power it could have when/if it breaks above .40 cents…remember when it broke .10 cents with conviction BOOM!” John Newell, Feb 16, 2021
  • American Creek Resources [TSXV:AMK] has been highlighted by MiningStockWatch.com as 1 of 2 listed “opportunities” on their site.

Sector Expert: John Newell

John Newell is a portfolio manager at Fieldhouse Capital Management and president and CEO of Golden Sky Minerals Corp. He has 38 years of experience in the investment industry acting as an officer, director, portfolio manager and investment advisor with some of the largest investment firms in Canada including Scotia McLeod, CIBC Wood Gundy and Richardson Greenshields (RBC Capital Markets). Newell is a specialist in precious metal equities and related commodities, and follows a disciplined proprietary approach incorporating equity research, analytical frameworks and risk controls to evaluate and select long and short stocks primarily from the Canadian small and mid-cap coverage. Many large, midcap and junior precious metal companies use his technical charts. Newell is a registered portfolio manager in Canada (advising representative).
 
Last week, sector expert John Newell put out a chart showing a possible “Sonic Boom” (as he puts it) in AMK stock similar to what the company experienced when it crossed the 10 cent threshold last year. 

He has updated the charts which are found below.

https://mcusercontent.com/af629dcbbf88a5932a7e484e3/images/a2bafd01-d146-4e4b-bb33-53ad57f849dd.png

American Creek Resources [TSXV:AMK] has been highlighted by MiningStockWatch.com as 1 of 2 listed “opportunities” on their site. To view the site click here.

The website is headed by John Newell and its mission is as follows:

To identify highly profitable trading and investment ideas in the precious metals, industrial metals, and strategic metals space, to help investors position themselves in a metals bull market that we believe has years of great returns ahead of itself.

While no small feat, we look for selected individual companies in this space that we feel the market has overlooked for whatever reasons and believe they will produce out sized returns, over a reasonable time frame. We believe this because our past ideas suggest it is possible. Starting in 2016 we uncovered, Teranga, Alacer, Atlantic Gold, Aurico, Lakeshore, Auryn, Claude, Dalradian, Integra, Kirkland Lake, Klondex, Newmarket, NovaGold, Premier Gold, Richmont, Equinox, Lundin Gold, Great Bear, Tudor, Imperial Metals and Westdome, to name a few. We did this at times when the timing was seemed unlikely or contrarian. We also had some ones that have not worked out yet, McEwen Mining, Almaden, Oceana Gold, because this is not a market sector that you do not experience some disappointment, or the investment time frame is pushed out a few years.

XPhyto Therapeutics $XPHY.ca $XPHYF Builds Commercial Team to Launch 25-Minute Covid-19 Test $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:32 AM on Monday, February 22nd, 2021
  • Expedited formation of commercial team to launch its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
  • Expects medical device manufacturer approval by the end of February
  • European regulatory approval as a commercial in vitro diagnostic device by early March.

XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company“), is pleased to announce that the Company has expedited the formation of an experienced commercial team to launch its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab was developed by XPhyto’s exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”). XPhyto expects 3a to receive ISO 13485 medical device manufacturer approval by the end of February and European regulatory approval as a commercial in vitro diagnostic device (CE-IVD) for Covid-ID Lab by early March.

The market launch team consists of world-class clinical and pharmaceutical executives and service providers who bring the experience and expertise necessary to effectively and rapidly drive the commercialization of Covid-ID Lab. Collectively, the team brings decades of experience in the biotech and pharmaceutical industries, including: executive leadership, business development, regulatory compliance, product launch, international marketing and sales, production, quality assurance, and M&A. In particular, members of the team have led medical diagnostic company growth from inception to over 500 million Euro per year in multinational sales.

“We are extremely fortunate to now have a team with deep expertise in medical diagnostic product commercialization. The team has extensive experience from regulatory approval to international production and sales,” said Hugh Rogers, CEO and Director of XPhyto. “As we near expected regulatory approval, XPhyto’s business is rapidly evolving from innovation to impact. We are working hard to put the Company in the best possible position to execute on our business strategy.”

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/755782-xphyto-builds-commercial-team-to-launch-25-minute-covid-19-rt-pcr-test/messages/2304693#message

VIDEO – VSBLTY Groupe $VSBY.ca $VSBGF Is Ramping Up in the Digital Display Space, with Three Major Deals in the Past Two Weeks $MARK $AT

Posted by AGORACOM-JC at 8:00 PM on Sunday, February 21st, 2021

Earlier this month we told you about VSBLTY Groupe Technologies (VSBY:CSE) (VSBGF:US), a disruptive computer vision software company that is using A.I. and Machine Learning to transform the retail and security industries. 

  • $VSBY Teaches Computers How to Interpret Surroundings. For example, detecting anomalies better than any human ever can
  • $VSBY Then Delivers the Context of Their Surroundings via Alerts, so that humans can make decisions and act on then faster than ever possible
  • $VSBY technology serves the dual function of both monitoring (i.e. a stadium, a store) and marketing (serving ads based on real-time demographics)

Since that first video, VSBLTY has issued three separate, major news releases:

  • On Feb 4, it partnered with 911inform on a deal to improve emergency response, safety & security in schools, hospitals & offices
  • On Feb 9, it unveiled a partnership with Ability Enterprise Co., which will see cutting-edge cameras integrated into a new media network of up to 10,000 convenience stores in Latin America.
  • On Feb 16, it penned a partnership with EOS Linx to provide a solar-powered security solution utilizing ai-driven proprietary software.

We sat down with Jay Hutton, VSBLTY’s co-founder, CEO and President, to break down the firm’s rapid expansion:

VIDEO – ThreeD Capital $IDK $IDKFF First Monthly NAV Is Just The Beginning Of Exponentially Growing Portfolio $INTL.ca $CRL.ca $WUHN

Posted by AGORACOM-JC at 7:53 PM on Sunday, February 21st, 2021
IDK-square-for-blog

VIDEO – Valeo Pharma $VPH $VPHIF Hesperco Capsules at Core of Montreal Heart Institute’s Coronavirus Clinical Trial $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 7:38 PM on Sunday, February 21st, 2021
Valeo Pharma (@valeo_pharma) | Twitter